pirbuterol acetate

pirbuterol acetate (MAXAIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

MAXAIR is a marketed brand name for pirbuterol acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

pirbuterol acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.